This meeting took place in 2017



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

PI3K Pathways in Immunology, Growth Disorders and Cancer (A6)


Organizer(s) Leon O. Murphy, Klaus Okkenhaug and Sabina C. Cosulich
January 19—23, 2017
Hilton Santa Fe Historic Plaza Hotel • Santa Fe, New Mexico USA
Discounted Abstract Deadline: Sep 21, 2016
Abstract Deadline: Oct 19, 2016
Scholarship Deadline: Sep 21, 2016
Discounted Registration Deadline: Nov 16, 2016

Sponsored by Bayer HealthCare Pharmaceuticals, Cell Signaling Technology, Inc., Incyte Corporation and Pfizer Inc.

Summary of Meeting:
The overall goal for this meeting is to bring together scientific leaders and trainees with a common interest in PI3Ks and relevant downstream physiological processes. It will address advances in basic molecular and cellular mechanisms that are regulated by PI3Ks, other PI kinases and, their cognate phosphatases; highlight new advances in the characterization of PI3K pathway alterations in genetic syndromes that affect growth and the immune and nervous systems; and provide an important update on the clinical development of PI3K pathway inhibitors, and implications for the burgeoning field of cancer immunotherapy. Whole exome sequencing studies have increasingly implicated PI3K signaling in diseases (immune, growth and neurological disorders) which may benefit from drugs currently in development for cancer and inflammation. This meeting will be an important forum for discussing approaches to treating these additional disorders.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Rafeah Alam
Babraham Institute, UK

Michael Ebner
Max F. Perutz Laboratories, Austria

Patsy R. Tomlinson
University of Cambridge, UK